Nalaganje...
Acquired Resistance to Targeted Therapies in Advanced Non-Small-Cell Lung Cancer: New Strategies and New Agents
While the transition to molecularly defined patient subgroups in advanced non-small cell lung cancer (NSCLC) often leads to dramatic and prolonged responses to an inhibitor of an identified oncogenic mutation, acquired resistance eventually ensues. The optimal approach to management in that setting...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4142045/ https://ncbi.nlm.nih.gov/pubmed/23714521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EdBook_AM.2013.33.e272 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|